Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Porter

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1997
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implicationsX Gao, A T Porter, K V Honn
Medical Physics|June 1, 1994
Measurement of augmentation of 252Cf implant by 10B and 157Gd neutron captureJ G Wierzbicki, Y Maruyama, A T Porter
American Journal of Clinical Oncology|June 1, 1993
Strontium 89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship?W C Mertens, L Stitt, A T Porter
Current Opinion in Oncology|November 1, 1994
Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rheniumA T Porter, E Ben-Josef, L Davis
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1992
Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinomaS L Breen, J E Powe, A T Porter
International Journal of Radiation Oncology, Biology, Physics|March 1, 1988
Remote interstitial afterloading in cancer of the prostate: preliminary experience with the MicroSelectronA T Porter, J W Scrimger, J S Pocha
Cancer|July 1, 1990
Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor markerG S Dundas, A T Porter, P M Venner
The Journal of Biological Chemistry|April 10, 1985
Investigation of the selectivity of hydrogen abstraction in the nonenzymatic formation of hydroxyeicosatetraenoic acids and leukotrienes by autoxidationA R Brash, A T Porter, R L Maas
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Modeling of internal dose distributions during SR-89 treatment of a patient with bone metastasesM M Bialkowski, J G Wierzbicki, A T Porter
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1991
Acute non-lymphocytic leukaemia and myelofibrosis following sequential hemibody irradiation for prostatic carcinomaI Chin-Yee, A T Porter, R C Lohmann
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Advances in Experimental Medicine and Biology|January 1, 1997
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implicationsX Gao, A T Porter, K V Honn
Medical Physics|June 1, 1994
Measurement of augmentation of 252Cf implant by 10B and 157Gd neutron captureJ G Wierzbicki, Y Maruyama, A T Porter
American Journal of Clinical Oncology|June 1, 1993
Strontium 89 therapy and relief of pain in patients with prostatic carcinoma metastatic to bone: a dose response relationship?W C Mertens, L Stitt, A T Porter
Current Opinion in Oncology|November 1, 1994
Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rheniumA T Porter, E Ben-Josef, L Davis
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1992
Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinomaS L Breen, J E Powe, A T Porter
International Journal of Radiation Oncology, Biology, Physics|March 1, 1988
Remote interstitial afterloading in cancer of the prostate: preliminary experience with the MicroSelectronA T Porter, J W Scrimger, J S Pocha
Cancer|July 1, 1990
Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor markerG S Dundas, A T Porter, P M Venner
The Journal of Biological Chemistry|April 10, 1985
Investigation of the selectivity of hydrogen abstraction in the nonenzymatic formation of hydroxyeicosatetraenoic acids and leukotrienes by autoxidationA R Brash, A T Porter, R L Maas
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Modeling of internal dose distributions during SR-89 treatment of a patient with bone metastasesM M Bialkowski, J G Wierzbicki, A T Porter
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1991
Acute non-lymphocytic leukaemia and myelofibrosis following sequential hemibody irradiation for prostatic carcinomaI Chin-Yee, A T Porter, R C Lohmann
Pageof 12